OneMedNet (NASDAQ:ONMD) CEO Buys $20,890.50 in Stock

OneMedNet Corporation (NASDAQ:ONMD) CEO Aaron Green acquired 36,650 shares of OneMedNet stock in a transaction on Tuesday, June 23rd. The stock was purchased at an average cost of $0.57 per share, for a total transaction of $20,890.50. Following the purchase, the chief executive officer owned 1,896,375 shares in the company, valued at approximately $1,080,933.75. The trade was a 1.97% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Aaron Green also recently made the following trade(s):

• On Monday, June 15th, Aaron Green bought 18,702 shares of OneMedNet stock. The shares were purchased at an average price of $0.54 per share, with a total value of $10,099.08.
• On Friday, June 12th, Aaron Green bought 36,920 shares of OneMedNet stock. The shares were purchased at an average price of $0.56 per share, with a total value of $20,675.20.

OneMedNet Stock Performance

ONMD stock opened at $0.66 on Friday. The firm has a fifty day moving average price of $0.81 and a 200 day moving average price of $0.90. OneMedNet Corporation has a fifty-two week low of $0.44 and a fifty-two week high of $4.22. The firm has a market cap of $35.93 million, a PE ratio of -13.20 and a beta of 1.12.

OneMedNet (NASDAQ:ONMD) last released its quarterly earnings results on Friday, May 15th. The company reported ($0.04) earnings per share (EPS) for the quarter. The company had revenue of $0.10 million for the quarter.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the stock. Wall Street Zen cut shares of OneMedNet from a “hold” rating to a “sell” rating in a research report on Saturday, May 23rd. Weiss Ratings reissued a “sell (e+)” rating on shares of OneMedNet in a research note on Monday, June 1st. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has an average rating of “Sell”.

Institutional Investors Weigh In On OneMedNet

Several institutional investors have recently made changes to their positions in the company. Virtu Financial LLC purchased a new position in shares of OneMedNet during the 4th quarter worth about $48,000. Jane Street Group LLC purchased a new stake in OneMedNet in the 4th quarter worth about $119,000. State Street Corp raised its position in OneMedNet by 41.5% in the 4th quarter. State Street Corp now owns 116,700 shares of the company’s stock worth $128,000 after purchasing an additional 34,200 shares during the period. HRT Financial LP bought a new stake in OneMedNet in the fourth quarter worth about $32,000. Finally, Exencial Wealth Advisors LLC lifted its stake in OneMedNet by 1.3% in the fourth quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company’s stock worth $4,009,000 after purchasing an additional 45,401 shares during the last quarter. Institutional investors own 0.95% of the company’s stock.

OneMedNet Company Profile

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.